3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Lymphoma, Large B-Cell, Diffuse
36
Multiple Myeloma
33
Burkitt Lymphoma
32
Lymphoma
30
Leukemia, Myeloid, Acute
29
Lymphoma, Non-Hodgkin
28
Recurrence
26
Breast Neoplasms
26
Neoplasms
23
Lymphoma, B-Cell
23
Myelodysplastic Syndromes
20
Lymphoma, Follicular
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Hodgkin Disease
17
Triple Negative Breast Neoplasms
16
Leukemia
16
Ovarian Neoplasms
15
Hematologic Neoplasms
15
Neuroblastoma
14
Melanoma
14
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Pancreatic Neoplasms
12
Lymphoma, Mantle-Cell
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Leukemia, Biphenotypic, Acute
10
Sarcoma
9
Osteosarcoma
9
Neoplasm Metastasis
9
Lymphoma, B-Cell, Marginal Zone
9
Interventions
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Liquid Biopsy
1
Laparoscopy
1
Epirubicin
1
Cyclophosphamide
1
Conversion to Open Surgery
1
Colonography, Computed Tomographic
1
Carboplatin
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Cyclophosphamide
×
90 days
×
Clear all
NCT04771871
2026-05-07
TARMAC
University College Hospital, Ibadan
Phase 2
Recruiting
42 enrolled